Document Type

Article

Publication Date

2-7-2018

JAX Source

Mol Ther 2018 Feb 7 26(2):524-541

Volume

26

Issue

2

First Page

524

Last Page

541

ISSN

1525-0024

PMID

29292161

DOI

https://doi.org/10.1016/j.ymthe.2017.11.019

Grant

European Research Council

Abstract

Retinal gene transfer with adeno-associated viral (AAV) vectors holds great promise for the treatment of inherited retinal degenerations (IRDs). One limit of AAV is its transfer capacity of about 5 kb, which can be expanded to about 9 kb, using dual AAV vectors. This strategy would still not suffice for treatment of IRDs such as Usher syndrome type 1D or Alström syndrome type I (ALMS) due to mutations in CDH23 or ALMS1, respectively. To overcome this limitation, we generated triple AAV vectors, with a maximal transfer capacity of about 14 kb. Transcriptomic analysis following triple AAV transduction showed the expected full-length products along a number of aberrant transcripts. However, only the full-length transcripts are efficiently translated in vivo. We additionally showed that approximately 4% of mouse photoreceptors are transduced by triple AAV vectors and showed correct localization of recombinant ALMS1. The low-photoreceptor transduction levels might justify the modest and transient improvement we observe in the retina of a mouse model of ALMS. However, the levels of transduction mediated by triple AAV vectors in pig retina reached 40% of those observed with single vectors, and this bodes well for further improving the efficiency of triple AAV vectors in the retina. Mol Ther 2018 Feb 7 26(2):524-541.

Comments

Open access under Creative Commons Attribution (CC BY) license (Creative Commons Attribution 4.0 International License).

Download

Share

COinS